Eloxx Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q2 2011 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Eloxx Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2011 to Q3 2023.
  • Eloxx Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2023 was 2.17M shares, a 97.5% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 2.17M -84.5M -97.5% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 2.17M -84.5M -97.5% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 2.17M -84.5M -97.5% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 2.17M +108 +0.01% Dec 31, 2022 10-Q 2023-11-13
Q3 2022 86.7M +404K +0.47% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 86.7M +454K +0.53% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 86.7M +46.4M +115% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 2.17M -38M -94.6% Dec 31, 2021 10-K 2023-03-31
Q3 2021 86.3M +46.1M +115% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 86.2M +46.1M +115% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 40.2M +89.4K +0.22% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 40.2M +126K +0.32% Dec 31, 2020 10-K 2022-03-30
Q3 2020 40.2M +173K +0.43% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 40.1M +221K +0.55% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 40.1M +4.18M +11.6% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 40M +4.17M +11.6% Dec 31, 2019 10-K 2021-03-12
Q3 2019 40M +4.85M +13.8% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 39.9M +5.05M +14.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 35.9M +8.42M +30.6% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 35.9M +8.33M +30.3% Dec 31, 2018 10-K 2020-03-06
Q3 2018 35.1M -16.3M -31.7% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 34.9M +5.67M +19.4% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 27.5M +607K +2.26% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 27.5M +23.3M +555% Dec 31, 2017 10-K 2019-03-14
Q3 2017 51.4M +30.9M +151% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 29.2M +8.71M +42.5% Jun 30, 2017 10-Q 2017-11-14
Q1 2017 26.9M +6.5M +31.8% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 4.21M -16.2M -79.4% Dec 31, 2016 10-K 2018-03-16
Q3 2016 20.5M +109K +0.53% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 20.5M +1.74M +9.3% Jun 30, 2016 10-K 2017-10-13
Q1 2016 20.4M +6.45M +46.1% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 20.4M +6.55M +47.3% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 20.4M +6.54M +47.2% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 18.8M +4.91M +35.4% Jun 30, 2015 10-K 2016-10-13
Q1 2015 14M +7.08M +103% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 13.9M +8.91M +180% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 13.8M +11.5M +490% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 13.8M +11.6M +509% Jun 30, 2014 10-K 2015-10-09
Q1 2014 6.9M -140M -95.3% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 4.96M -112M -95.8% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 2.35M -114M -98% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 2.27M -91.8M -97.6% Jun 30, 2013 10-K 2014-09-29
Q1 2013 147M +55.1M +60% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 117M +36.1M +44.7% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 117M +37.1M +46.5% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 94.1M +16.3M +21% Jun 30, 2012 10-K 2013-09-11
Q1 2012 91.9M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 80.9M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 79.7M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 77.8M Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.